Diagnostic and therapeutic interventions in patients with antithrombotic medication: What should be considered? Response

被引:0
|
作者
Riess, Hanno [1 ]
机构
[1] Charite Univ Med Berlin, Med Klin Schwerpunkt Hamatol & Onkol, D-13353 Berlin, Germany
关键词
D O I
10.1055/s-2006-957191
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2797 / 2798
页数:2
相关论文
共 50 条
  • [1] Diagnostic and therapeutic interventions in patients with antithrombotic medication: What is to be considered?
    Klauss, V.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (49) : 2797 - 2797
  • [2] What should be considered a startle response?
    Hackley, S
    van Boxtel, A
    PSYCHOPHYSIOLOGY, 2003, 40 : S13 - S13
  • [3] Should patients be on antithrombotic medication for their first arteriovenous fistulae?
    Murley, Alexander
    Wijewardane, Anika
    Wilmink, Teun
    Baharani, Jyoti
    JOURNAL OF VASCULAR ACCESS, 2016, 17 (02): : 118 - 123
  • [4] The impact of preinjury antithrombotic medication on hemostatic interventions in trauma patients
    Kudo, Daisuke
    Kushimoto, Shigeki
    Shiraishi, Atsushi
    Ogura, Hiroshi
    Hagiwara, Akiyoshi
    Saitoh, Daizoh
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2017, 35 (01): : 62 - 65
  • [5] Elderly patients with unexplained syncope: What should be considered a positive tilt test response?
    de Castro, Renata Rodrigues Teixeira
    da Nobrega, Antonio Claudio Lucas
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2006, 126 : 169 - 173
  • [6] OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
    Dressler, Dirk
    BRAIN, 2020, 143
  • [7] Switch Therapy: What Should Be Considered in Patients Using Antimicrobials?
    Barbara Barduchi Oliveira da Silva
    Alessandra Gomes Chauvin
    Leandro Martins dos Santos
    Gabrielli Pare Guglielmi
    Silvana Maria de Almeida
    Current Treatment Options in Infectious Diseases, 2024, 16 : 1 - 13
  • [8] Switch Therapy: What Should Be Considered in Patients Using Antimicrobials?
    da Silva, Barbara Barduchi Oliveira
    Chauvin, Alessandra Gomes
    dos Santos, Leandro Martins
    Guglielmi, Gabrielli Pare
    de Almeida, Silvana Maria
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2024, 16 (01) : 1 - 13
  • [9] Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
    Pijpers, Judith A.
    Ferrari, Michel D.
    Terwindt, Gisela M.
    BRAIN, 2020, 143
  • [10] WHAT PATIENTS WITH HYPERTENSION SHOULD KNOW ABOUT THEIR MEDICATION
    BULLEN, MU
    DRUGS, 1980, 19 (05) : 373 - 379